Six-Month Financial Reconciliation
Period ended Period ended
June 30, 2009 June 30, 2008
Total Revenue $3,185,269 $3,183,980
Bulk Cobalt Products Revenue $494,661 $488,256
Adjusted Revenues Excluding
Bulk Cobalt Products
Revenue $2,690,608 $2,695,724
Revenue From The Sale Of Radiochemical Products:
Revenue from the sale of radiochemical products for the three-month period ending June 30, 2009, was $398,895 compared to $349,990 for the same period in 2008. This represents an increase in revenue of $48,905, or about 14%. Revenue from the sale of radiochemical products for the six-month period ending June 30, 2009, was $747,666 compared to $668,398 for the same period in 2008. This represents an increase in revenue of $79,268, or about 12%. Increases in the segment performance are attributable to increased sales of radiochemical iodine-131.
Revenue From The Sale of Nuclear Medicine Products:
Revenue from nuclear medicine products for the three-month period ending June 30, 2009 was $466,113 compared to $464,288 for the same period in 2008. This represents an increase in revenue of $1,825, or less than 1%. Revenue from nuclear medicine products for the six-month period ending June 30, 2009 was $955,099 compared to $911,698 for the same period in 2008. This represents an increase in revenue of $43,401, or about 5%.
| SOURCE International Isotopes Inc. Copyright©2009 PR Newswire. All rights reserved |